(Q45412287)

English

A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues

scientific article published in August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Münci Yağci

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Kadir Acar

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Gülsan Türköz Sucak

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Zeynep Aki

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Gülendam Bozdayi

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Rauf Haznedar

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1608-1612

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Lamivudine therapy for acute hepatitis B infection following peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500472974

21 January 2018

Identifiers

10.1080/10428190500472974

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45412287&oldid=2076845355"